Colwell, A.R. , Jr., Colwell, J.A. and Colwell, A.R.: Intrapancreatic perfusion of the antidiabetic sulfonylureas. Metabolism5: 749-756, 1956.
2.
Diabetes: A monograph, published by the Upjohn Company, Kalamazoo, Michigan, 1960.
3.
Duncan, G.C. : Clinical experience with chloropropamide in the treatment of diabetes. Diabetes8: 364-370, 1959.
4.
Marble, A., White, P., Belmonte, M. and Sargeant, L.: Rafael Camerini-Davalos—Effect of sulfonylurea compounds in diabetic children. New Eng. J. Med.256: 817-822, 1957.
5.
McCullagh, E.P. and Goebert, H.W., Jr.: Effects of insulin with and without tolbutamide in a depancreatized woman. Diabetes8: 315-316, 1959.
6.
Pfizer Laboratories pamphlet No. W8 059-10-8, Chas. Pfizer and Co., Brooklyn 6, New York.
7.
Root, M.A., Sigal, M.V. and Anderson, R.C.: Pharmacology of 1-(p-chlorobenzene-sulfonyl)-3-n propylurea (chloropropamide) . Diabetes8: 7-13, 1959.
8.
Stewart, R.C. , Piazza, E.U., Hyman, H., III and Hurwitz , D.: Chloropropamide therapy of diabetes. New Eng. J. Med.261: 427-430, 1959.
9.
The Merck Index of Chemicals and Drugs. Paul G. Stecher, Editor. Published by Merck and Co. , Rahway, New Jersey, 1960.
10.
Wrenshall, G.A. and Best, C.H.: Extractable insulin of the pancreas and effectiveness of oral hypoglycemic sulfonylureas in the treatment of diabetes in man—a comparison. Canadian Med. Assoc. J.74: 968-972, 1956.
